NCT Number: NCT00006169
Behavioral Treatment of Weight Gain in CF
The current study examines the efficacy of two treatments to help children with cystic fibrosis (CF) meet their dietary calorie requirements of 120% to 150% of the recommended daily allowance of energy and the effect of these treatments on weight gain and maintenance. One treatment provides children with CF and their parents nutrition education about the best foods for meeting their dietary needs. The second treatment gives children with CF and their families similar nutritional information plus behavioral parenting methods for motivating children to eat the recommended foods. Children with CF and their families are seen weekly for 7 treatment sessions across 9 weeks for the active phase of treatment. Families are then followed for 2 years after treatment in order to better understand how long the treatments are effective and to determine the health benefits of better nutrition status and weight gain.
Looking for future studies?
Notify MeKey information
Conditions
Age range
4 year–12 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
University of Florida, Gainesville, Florida, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Weight percentile for age or height below 40th for age and sex
- Pancreatic insufficiency
Exclusion criteria
- Developmental delays
- Pseudomonas cepacia
- Supplemental enteral or parenteral nutrition
Treatment and study plan
Sponsors and collaborators
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nih
Registry information
Important dates
- Study start
- 1996
- Study completion
- 1999
- First posted
- Aug 9, 2000
- Registry last updated
- Mar 2, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study
NCT02715921
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Irvine, California, United States
View Trial DetailsHERO-2: Home-Reported Outcomes With CFTR Modulator Therapy
NCT04798014
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Indianapolis, Indiana, United States
View Trial DetailsPeer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
NCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsA Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa
NCT05453578
Bacterial Disease Carrier, Bacterial Infections
Tucson, Arizona, United States
View Trial Details